My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Mesa Laboratories, Inc. - Common Stock (NQ:MLAB)

93.67 +5.04 (+5.69%)

Streaming Delayed Price Updated: 3:23 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Mesa Laboratories, Inc. - Common Stock

< Previous 1 2 Next >

Mesa Laboratories: Q2 Earnings Insights ↗

November 03, 2022

Mesa Laboratories (NASDAQ:MLAB) reported its Q2 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Mesa Laboratories posted...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Mesa Laboratories's Return on Invested Capital Insights ↗

August 22, 2022

According to Benzinga Pro data, during Q1, Mesa Laboratories (NASDAQ:MLAB) posted sales of $50.45 million. Earnings were up 19.39%, but Mesa Laboratories still reported an overall loss of $1.44...

Via Benzinga

Mesa Laboratories: Q1 Earnings Insights ↗

August 04, 2022

Mesa Laboratories (NASDAQ:MLAB) reported its Q1 earnings results on Thursday, August 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Mesa Laboratories: Q4 Earnings Insights ↗

May 31, 2022

Mesa Laboratories (NASDAQ:MLAB) reported its Q4 earnings results on Tuesday, May 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Mesa Laboratories: Q3 Earnings Insights ↗

February 03, 2022

Mesa Laboratories (NASDAQ:MLAB) reported its Q3 earnings results on Thursday, February 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

How Good Are Mesa Laboratories's Earnings? | Return On Invested Capital ↗

November 08, 2021

According to Benzinga Pro, during Q2, Mesa Laboratories (NASDAQ:MLAB) earned $4.20 million, a 34.52% increase from the preceding quarter. Mesa Laboratories also posted a total of...

Via Benzinga

Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M ↗

September 14, 2021

Mesa Laboratories Inc (NASDAQ: MLAB) has agreed to acquire Agena Bioscience Inc for a cash purchase price of $300 million. The San Diego, California-based...

Via Benzinga

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Looking Into Mesa Laboratories's Return On Capital Employed ↗

September 08, 2021

According to Benzinga Pro, during Q1, Mesa Laboratories (NASDAQ:MLAB) earned $3.12 million, a 27.3% increase from the preceding quarter. Mesa Laboratories's sales decreased to $34...

Via Benzinga

Looking Into Mesa Laboratories's Return On Capital Employed ↗

July 07, 2021

Looking at Q4, Mesa Laboratories (NASDAQ:MLAB) earned $4.30 million, a 19427.27% increase from the preceding quarter. Mesa Laboratories also posted a total of $37.96 million in...

Via Benzinga

Mesa Laboratories: Q4 Earnings Insights ↗

June 01, 2021

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98,...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.